Cavernous Nerve Injury Resulted Erectile Dysfunction and Regeneration

Area of Science:

• Urology
• Regenerative Medicine
• Neuroscience

Background:

• Erectile dysfunction (ED) significantly impacts quality of life.
• Cavernous nerve injury (CNI) during pelvic surgery leads to CNIED in over 80% of patients.
• Current ED treatments show limited efficacy for CNIED.

Purpose of the Study:

• To review the causes, mechanisms, and current treatments for CNIED.
• To explore novel therapeutic strategies for nerve protection and regeneration in CNIED patients.
• To highlight emerging treatments for cavernous nerve injury erectile dysfunction.

Main Methods:

• Literature review of CNIED causes and mechanisms.
• Analysis of current and emerging treatment modalities.
• Synthesis of research on neuroprotection, gene therapy, stem cell therapy, and shock wave therapy.

Main Results:

• CNIED is a frequent complication of prostate cancer and pelvic surgeries.
• Existing ED treatments are often insufficient for surgically induced nerve damage.
• Promising preclinical and early clinical data exist for novel regenerative approaches.

Conclusions:

• Cavernous nerve injury erectile dysfunction presents a significant clinical challenge.
• Advanced therapies offer potential for nerve regeneration and functional recovery.
• Neuromodulatory proteins, gene therapy, stem cell therapy, and shock wave therapy are key areas for future CNIED treatment.